Tumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts. [electronic resource]
- American journal of nuclear medicine and molecular imaging 2015
- 493-503 p. digital